- 入驻时间: 2012-04-17
- 联系人:客户经理
- 电话:400-968-7988
-
联系时,请说明易展网看到的
- Email:fuwu@bioleaf.com
产品介绍 |
|||
品名 |
Quidel Polyclonal Antiserum to Human C7 Protein |
||
货号 |
A308 |
||
规格 |
2.0 mL |
||
形式 |
Whole Antiserum |
||
防腐剂 |
≤ 0.1% Sodium Azide |
||
物种交叉反应 |
Baboon, Guinea Pig, Cat, Rabbit, Hamster, Horse |
||
储存 |
2°C to 8°C (≤ 30 days) For long-term storage (> 30 days), aliquot and store at ≤ –20°C. Avoid repeated freeze-thaw. |
||
使用说明 |
For Research Use Only. Not for use in diagnostic procedures |
||
产品描述 |
Highly purified human C7 was isolated from normal serum and used to immunize goats. The anti-human C7 polyclonal antisera was tested against normal human plasma by double immunodiffusion, one-dimensional immunoelectrophoresis, quantitative radial immunodiffusion, and quantitative rocket immunoelectrophoresis. The antiserum was determined to be monospecific for C7 at varying concentrations.
Quidel Polyclonal Antiserum to Human C7 Protein |
||
背景 |
C7 is a glycoprotein which is present in normal human serum/plasma at approximately 55 µg/mL. Primarily synthesized in the liver, C7 is a single-chain protein with a molecular weight of approximately 95 kD. This complement protein is key for the continued formation of the SC5b-9 complex after C5b binds to C6
With activation of the classical or alternative pathways of the complement system, C5 convertase cleaves the C5
chain into C5a and C5b. C5b remains bound to the convertase and will combine with C6 to form a C5b,6 complex.
This complex normally interacts with C7 to form C5b,6,7 that becomes partially embedded in the target cell outer
membrane. |
||
应用 |
Applications of the C7 polyclonal antisera have been evaluated by various research facilities, and include, Western Blot, 1 Radial Immunodiffusion, 2 Immunofluorescence3 and Immunoblot. 4 |
||
参考文献 |
1、Yasojima, K., et al. “Up-Regulated Production and Activation of the Complement System in Alzheimer’s Disease Brain.” Am. J. of Pathology (1999): 927-936. 2、Kolb, W., et al. “Neoantigens of the Membrane Attack Complex of Human Complement.” Proceedings of the Nat. Acad. of Sciences (1975): 1687-1689. 3、Meri, S., et al. “Activation of the Alternative Pathway of Complement by Monoclonal Light Chains in Membranoproliferative Glomerulonephritis.” J. of Experimental Medicine (1992): 939- 95
|